Selected article for: "effective vaccine and vaccine development"

Author: Scott, E. M.; Magaret, A.; Kuypers, J.; Tielsch, J. M.; Katz, J.; Khatry, S. K.; Stewart, L.; Shrestha, L.; LeClerq, S. C.; Englund, J. A.; Chu, H. Y.
Title: Risk factors and patterns of household clusters of respiratory viruses in rural Nepal
  • Document date: 2019_10_14
  • ID: 1qgaxcqq_2
    Snippet: Household surveillance can provide valuable information regarding the transmission networks within households. Such knowledge may guide the development and implementation of preventative interventions to protect vulnerable groups from ALRI. For example, infants are at highest risk for severe ALRI from respiratory syncytial virus (RSV) [9] . Major challenges to developing a safe and effective RSV vaccine in young infants have resulted in the devel.....
    Document: Household surveillance can provide valuable information regarding the transmission networks within households. Such knowledge may guide the development and implementation of preventative interventions to protect vulnerable groups from ALRI. For example, infants are at highest risk for severe ALRI from respiratory syncytial virus (RSV) [9] . Major challenges to developing a safe and effective RSV vaccine in young infants have resulted in the development of alternative strategies including maternal RSV vaccination and delayed vaccine administration until >6 months of age [10] . Targeting older groups for vaccination may protect vulnerable populations by interfering in transmission chains to young infants, the elderly and other high-risk groups.

    Search related documents:
    Co phrase search for related documents
    • alternative strategy and high risk group: 1
    • alternative strategy and major challenge: 1, 2, 3
    • alternative strategy and maternal RSV vaccination: 1
    • alternative strategy and old group: 1
    • alternative strategy and respiratory syncytial virus: 1
    • alternative strategy and RSV vaccination: 1
    • alternative strategy and syncytial virus: 1
    • alternative strategy and vaccine administration: 1, 2
    • alternative strategy and valuable information: 1, 2
    • alternative strategy and vulnerable group: 1
    • alternative strategy and vulnerable population: 1, 2
    • delayed vaccine administration and vaccine administration: 1
    • elderly high risk group and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • elderly high risk group and high risk group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • elderly high risk group and major challenge: 1
    • elderly high risk group and respiratory syncytial virus: 1